Inovalon Holdings Inc INOV, a technology company providing cloud-based platforms to the health care industry, is beset by client losses, ACA headwinds and pricing concerns, an analyst at Morgan Stanley said. The Analyst Morgan Stanley's Ricky Goldwasser downgraded Inovalon from Equal-weight to Underweight and lowered her price target from $15 to $10. The Thesis Inovalon's return to 10 percent organic growth could now take longer than expected, given a contract loss post September 2017, ACA headwinds and CFO departure, Goldwasser said in a note. SourceSome downside still holds, but correction may come soon. $INOV, Inovalon Holdings, Inc. / D